Orient Pharma and TraceLink Partner for Global Serialization Strategy
For Orient Pharma, a global pharmaceutical manufacturer based in Taiwan with serialization requirements in multiple countries, finding a global compliance partner was top of mind. In this video, learn how TraceLink enables Orient Pharma to deliver serialization on a global scale, seamlessly integrate with trading partners, and enhance the quality of their operations.
TraceLink Announces New Digital Network Platform
Built on top of the TraceLink Digital Supply Network with 276,000+ trading partners, the platform will allow users to design and deploy applications, driving innovation and enabling patient-centric orchestration across the end-to-end life sciences value chain.
DSCSA Saleable Returns Enforcement Discretion; A Letter from TraceLink’s CEO
The FDA has announced a 12-month delay in enforcement action for the DSCSA saleable returns verification requirement applicable to wholesale distributors but not to manufacturers. What does this mean for the industry? In an open letter, TraceLink’s President and CEO, Shabbir Dahod, shares his insights.